Audit 359619

FY End
2024-12-31
Total Expended
$83.78M
Findings
0
Programs
49
Organization: Geisinger Health (PA)
Year: 2024 Accepted: 2025-06-24
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $40.33M - 0
84.268 Federal Direct Student Loans $20.56M - 0
93.399 Cancer Control $1.61M Yes 0
93.359 Nurse Education, Practice Quality and Retention Grants $884,027 - 0
93.945 Assistance Programs for Chronic Disease Prevention and Control $769,618 Yes 0
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $738,876 - 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $590,395 Yes 0
93.426 The National Cardiovascular Health Program $561,659 Yes 0
93.884 Primary Care Training and Enhancement $516,921 - 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $473,882 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $385,011 - 0
93.732 Mental and Behavioral Health Education and Training Grants $371,298 - 0
93.738 Pphf: Racial and Ethnic Approaches to Community Health Program Financed Solely by Public Prevention and Health Funds $368,844 - 0
93.855 Allergy and Infectious Diseases Research $368,810 Yes 0
93.172 Human Genome Research $320,246 Yes 0
93.233 National Center on Sleep Disorders Research $283,552 Yes 0
93.242 Mental Health Research Grants $246,684 Yes 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $224,683 - 0
93.211 Telehealth Programs $216,424 - 0
93.279 Drug Use and Addiction Research Programs $197,969 Yes 0
93.155 Rural Health Research Centers $187,417 - 0
84.063 Federal Pell Grant Program $186,324 - 0
10.001 Agricultural Research Basic and Applied Research $185,403 Yes 0
93.788 Opioid Str $123,788 - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $123,230 Yes 0
20.513 Enhanced Mobility of Seniors and Individuals with Disabilities $123,200 - 0
16.575 Crime Victim Assistance $105,318 - 0
93.839 Blood Diseases and Resources Research $98,809 Yes 0
93.837 Cardiovascular Diseases Research $61,659 Yes 0
93.859 Biomedical Research and Research Training $54,093 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $52,011 Yes 0
16.758 Improving the Investigation and Prosecution of Child Abuse and the Regional and Local Children's Advocacy Centers $49,135 - 0
93.310 Trans-Nih Research Support $43,258 Yes 0
47.075 Social, Behavioral, and Economic Sciences $41,991 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $39,117 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $31,809 - 0
93.393 Cancer Cause and Prevention Research $19,944 Yes 0
93.394 Cancer Detection and Diagnosis Research $13,790 Yes 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $10,289 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $4,724 Yes 0
93.865 Child Health and Human Development Extramural Research $3,896 Yes 0
93.866 Aging Research $2,627 Yes 0
93.758 Preventive Health and Health Services Block Grant Funded Solely with Prevention and Public Health Funds (pphf) $1,155 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $190 Yes 0
93.395 Cancer Treatment Research $96 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $-4,189 Yes 0
47.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $-9,146 Yes 0
93.838 Lung Diseases Research $-19,248 Yes 0
93.867 Vision Research $-35,377 Yes 0

Contacts

Name Title Type
JQH2GEMCAVN5 Erin Fitzgerald Auditee
5702142299 Eric Forkner Auditor
No contacts on file

Notes to SEFA

Title: Reporting Entity Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. Geisinger includes all federal expenditures in its consolidated schedule of expenditures of federal awards (the Schedule) administered by all entities included in its consolidated financial statements. Specifically, the Schedule includes expenditures of the following entities: Geisinger Clinic (identification number 23-6291113); Geisinger Medical Center (identification number 24-0795959); Geisinger Wyoming Valley Medical Center (identification number 23 1996150); Geisinger Community Health Services (identification number 23 2967235); Geisinger Bloomsburg Hospital (identification number 23-2193572); Geisinger Lewistown Hospital (identification number 23 1352187); Geisinger Community Medical Center (identification number 24 0862246); Geisinger Health Plan (identification number 23-2311553); Geisinger Jersey Shore Hospital (identification number 24-0792115); and Geisinger Commonwealth School of Medicine (identification number 26-0812968).The Schedule details transactions between Geisinger and Kaiser Foundation Hospitals (KFH) and its subsidiaries (see note 1 of the consolidated financial statements). For the year ended December 31, 2024, Geisinger transferred grants totaling $474,833 from ALN 93.393 and $190 from ALN 93.353 to KFH, which is included in amounts provided to subrecipients on the Schedule. Additionally, the Schedule includes expenditures totaling $11,490 from ALN 93.279 received as subawards from KHF.
Title: Basis of Preparation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. The accompanying Schedule includes all the federal award programs activity of Geisinger under programs of the federal government for the year ended December 31, 2024. The information in this Schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). The Schedule presents only a selected portion of the operations of Geisinger, and it is not intended to and does not present the consolidated financial position, results of operations, or cash flows of Geisinger.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements.
Title: Indirect Cost Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. Geisinger has not elected to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
Title: Federal Direct Loan Program Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. For the Federal Direct Student Loan Program, Geisinger is only responsible for the performance of certain administrative duties; therefore, the associated net assets and transactions are not included in Geisinger’s consolidated financial statements and it is not practicable to determine the balances of loans outstanding to students of Geisinger under this program at December 31, 2024. The Schedule includes the amounts loaned to students during the year ended December 31, 2024.
Title: Program Expenditures Incurred in Prior Years Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. De Minimis Rate Used: N Rate Explanation: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance and 45 CFR Part 75 Appendix E, hospital cost principles, wherein certain types of expenditures are not allowable or are limited as reimbursement. Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the consolidated financial statements. During the year ended December 31, 2024, the Pennsylvania Emergency Management Agency subawarded to Geisinger federal funding obligated in 2024 by the U.S. Department of Homeland Security through the Federal Emergency Management Agency totaling $40,325,217 for various project expenditures that were incurred in prior years.